DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR IN SERUM AND TISSUE OF PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Pistola, L. [1 ]
Ludovini, V. [1 ]
Gregorc, V. [2 ]
Bellezza, G. [3 ]
Darwish, S. [1 ]
Rulli, E. [4 ]
Compagnoni, A. [4 ]
Sidoni, A. [3 ]
Scheibel, M. [3 ]
Myhailova, Z. [1 ]
Ragusa, M. [5 ]
Di Carlo, L. [5 ]
Tofanetti, F. R. [1 ]
Bellet, M. M. [1 ]
Ferraldeschi, M. [1 ]
Daddi, G. [5 ]
Tonato, M. [1 ]
机构：
[1] Med Oncol Azienda Osped, Perugia, Italy
[2] S Raffaele Sci Inst, Div Oncol, Milan, Italy
[3] Univ Perugia, Inst Pathol, I-06100 Perugia, Italy
[4] Biometry Unit Oncol Ist Mario Negri, Milan, Italy
[5] Azienda Osped, Dept Thorac Surg, Perugia, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] Epidermal growth factor receptor mutations in female patients with postoperative recurrent non-small-cell lung cancer
    Na, Im Il
    Kim, Hye-Ryoun
    Lee, Jin Kyung
    Park, Sun Hoo
    Kim, Cheol Hyeon
    Koh, Jae Soo
    Baek, Hee Jong
    Choe, Du Hwan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (03) : 373 - 378
  • [22] Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer
    Swinson, Daniel Edmund Bryan
    O'Byrne, Kenneth John
    CLINICAL LUNG CANCER, 2006, 7 (04) : 250 - 256
  • [23] Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer
    Zhang, Yongjun
    Bao, Wenlong
    Li, Zhijun
    MEDICAL PRINCIPLES AND PRACTICE, 2015, 24 (05) : 486 - 490
  • [24] Epidermal growth factor receptor (EGFR) inhibition on non-small-cell lung cancer treatment
    Kowalski, Dariusz M.
    Krzakowski, Maciej
    Janowicz-Zebrowska, Anna
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (04): : 177 - 182
  • [25] Role of Epidermal Growth Factor Receptor Inhibitors in Epidermal Growth Factor Receptor Wild-Type Non-Small-Cell Lung Cancer
    Laurie, Scott A.
    Goss, Glenwood D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) : 1061 - 1069
  • [26] Epidermal Growth Factor Receptor (EGFR) mutation testing in non-small cell lung cancer (NSCLC) patients
    Eaton, Helen
    Dutton, L.
    Wallace, A. J.
    Howard, E.
    Gaunt, L.
    Blackhall, F.
    Newman, W.
    JOURNAL OF MEDICAL GENETICS, 2011, 48 : S72 - S72
  • [27] Epidermal Growth Factor Receptor (EGFR) Mutation Testing in non-small cell lung cancer (NSCLC) patients
    Wallace, Andrew
    Howard, E.
    Dutton, L.
    Elles, R. G.
    Newman, W.
    JOURNAL OF MEDICAL GENETICS, 2010, 47 : S66 - S66
  • [28] Clinical significance of serum hepatocyte growth factor (sHGF) in patients with advanced non-small-cell lung cancer (NSCLC).
    Tsuji, Takahiro
    Sakamori, Yuichi
    Ozasa, Hiroaki
    Ajimizu, Hitomi
    Yagi, Yoshitaka
    Nagai, Hiroki
    Mishima, Michiaki
    Kim, Young Hak
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Delivery of siRNA Targeting Epidermal Growth Factor Receptor (EGFR) as a Therapeutic Strategy Against Non-Small-Cell Lung Cancer (NSCLC)
    Man, Rico Chi Hang
    Lo, Jason Chun Kit
    Lam, Jenny Ka Wing
    MOLECULAR THERAPY, 2020, 28 (04) : 466 - 466
  • [30] Erlotinib customization based on epidermal growth factor receptor (EGFR) mutations in stage IV non-small-cell lung cancer (NSCLC) patients (p)
    Porta, R.
    Queralt, C.
    Cardenal, F.
    Mayo, C.
    Provencio, M.
    Camps, C.
    Isla, D.
    Gonzalez-Larriba, J.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345